Weed (BUDZ) Change in Accured Expenses (2010 - 2026)
Weed (BUDZ) posted quarterly Change in Accured Expenses of $73412.0 for Q1 2026, up 65.13% year-over-year from $44456.0 in Q1 2025, and up 27.64% quarter-over-quarter from $57514.0 in Q4 2025.
Weed (BUDZ) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Weed's Change in Accured Expenses history runs 13 years deep, the most recent figure standing at $73412.0 for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 65.13% year-over-year to $73412.0; the TTM figure through Mar 2026 stood at $238919.0 (down 16.51% YoY), while the FY2025 annual figure was $209963.0, up 374.78% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $73412.0, up from $57514.0 in the prior quarter.
- The five-year high for Change in Accured Expenses was $167635.0 in Q2 2024, with the low at -$206812.0 in Q3 2023.
- The 5-year median for Change in Accured Expenses is $26394.0 (2024), against an average of $11208.2.
- Peak annual rise in Change in Accured Expenses reached 800.68% in 2024, while the deepest fall reached 2029.99% in 2024.
- Weed's Change in Accured Expenses stood at $7789.0 in 2022, then plunged by 429.61% to -$25673.0 in 2023, then surged by 202.81% to $26394.0 in 2024, then surged by 117.91% to $57514.0 in 2025, then advanced by 27.64% to $73412.0 in 2026.
- Business Quant data shows BUDZ's Change in Accured Expenses at $73412.0 in Q1 2026, $57514.0 in Q4 2025, and $54026.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.96 Bn | 43.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.23 Bn | 39.58 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 31.76 Bn | 30.08 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.68 Bn | 22.88 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.69 Bn | 17.81 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 11.78 Bn | 11.25 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | Weed | 2.88 Mn | 2.88 Mn | - | 61,791.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73,412.00 |
| Mar 31, 2026 | 73,412.00 |
| Dec 31, 2025 | 57,514.00 |
| Dec 31, 2025 | 57,514.00 |
| Sep 30, 2025 | 54,026.00 |
| Sep 30, 2025 | 54,026.00 |
| Jun 30, 2025 | 53,967.00 |
| Jun 30, 2025 | 53,967.00 |
| Mar 31, 2025 | 44,456.00 |
| Mar 31, 2025 | 44,456.00 |
| Dec 31, 2024 | 26,394.00 |
| Dec 31, 2024 | 26,394.00 |
| Sep 30, 2024 | 47,665.00 |
| Sep 30, 2024 | 47,665.00 |
| Jun 30, 2024 | 167,635.00 |
| Jun 30, 2024 | 167,635.00 |
| Mar 31, 2024 | -197,471.00 |
| Mar 31, 2024 | -197,471.00 |
| Dec 31, 2023 | -25,673.00 |
| Dec 31, 2023 | -25,673.00 |